HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li Jia Selected Research

Callosities

4/2009Comparison of field-enhanced and pressure-assisted field-enhanced sample injection techniques for the analysis of water-soluble vitamins using CZE.
2/2009Pressurized CEC with gradient elution for separation of flavonoids from corn.
1/2009Capillary liquid chromatographic analysis of fat-soluble vitamins and beta-carotene in combination with in-tube solid-phase microextraction.
3/2008On-line concentration and pressurized capillary electrochromatographic analysis of phytohormones in corn.
6/2007Pressurized capillary electrochromatographic analysis of water-soluble vitamins by combining with on-line concentration technique.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li Jia Research Topics

Disease

127Neoplasms (Cancer)
10/2022 - 02/2004
32Neoplasm Metastasis (Metastasis)
07/2022 - 06/2006
27Prostatic Neoplasms (Prostate Cancer)
01/2022 - 03/2003
26Breast Neoplasms (Breast Cancer)
07/2022 - 11/2007
18Hepatocellular Carcinoma (Hepatoma)
11/2021 - 06/2006
15Carcinogenesis
01/2022 - 06/2006
10Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2017
8Leukemia
05/2019 - 12/2008
7Inflammation (Inflammations)
05/2021 - 10/2013
7Lung Neoplasms (Lung Cancer)
01/2021 - 04/2016
6Lymphatic Metastasis
06/2021 - 06/2006
6Ovarian Neoplasms (Ovarian Cancer)
11/2019 - 06/2008
6B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2019 - 03/2008
5Obesity
08/2021 - 05/2017
5Insulin Resistance
08/2021 - 05/2017
5Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 12/2015
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020 - 01/2012
5Callosities
04/2009 - 06/2007
4Stomach Neoplasms (Stomach Cancer)
01/2022 - 10/2010
4Melanoma (Melanoma, Malignant)
01/2022 - 01/2017
4Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 04/2015
4Metabolic Diseases (Metabolic Disease)
08/2021 - 05/2019
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2020 - 09/2014
4Infections
01/2020 - 06/2008
4Adenocarcinoma
09/2019 - 02/2015
4Fibrosis (Cirrhosis)
06/2019 - 01/2016
3Type 2 Diabetes Mellitus (MODY)
08/2021 - 05/2019
3Non-alcoholic Fatty Liver Disease
05/2021 - 11/2016
3Mitochondrial Diseases (Mitochondrial Disease)
05/2021 - 01/2013
3Wounds and Injuries (Trauma)
05/2021 - 01/2013
3Chronic Kidney Failure (Chronic Renal Failure)
05/2021 - 12/2017
3Pain (Aches)
05/2021 - 01/2016
3Myocarditis (Carditis)
01/2019 - 01/2018
3Dermatitis
01/2019 - 01/2016
3Lymphoma (Lymphomas)
01/2019 - 01/2007
3Carcinoma (Carcinomatosis)
01/2019 - 02/2014
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2017 - 09/2016
3Hypoxia (Hypoxemia)
01/2017 - 08/2009
3Ventricular Tachycardia
01/2013 - 06/2011
3Ventricular Premature Complexes (Premature Ventricular Contraction)
01/2013 - 06/2011
2Parkinson Disease (Parkinson's Disease)
07/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

30MicroRNAs (MicroRNA)IBA
01/2022 - 08/2015
26Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2004
18Androgen Receptors (Androgen Receptor)IBA
01/2019 - 04/2004
17Biomarkers (Surrogate Marker)IBA
07/2022 - 01/2007
15Pharmaceutical PreparationsIBA
09/2021 - 05/2012
12Long Noncoding RNAIBA
04/2022 - 01/2018
11Polysaccharides (Glycans)IBA
06/2022 - 02/2013
10AndrogensIBA
01/2019 - 09/2004
8AntigensIBA
07/2022 - 09/2014
8Messenger RNA (mRNA)IBA
01/2022 - 02/2008
8CytokinesIBA
01/2020 - 02/2013
8Doxorubicin (Adriamycin)FDA LinkGeneric
08/2019 - 11/2012
8LigandsIBA
01/2019 - 03/2003
8TeaIBA
12/2013 - 11/2007
6Glycoproteins (Glycoprotein)IBA
01/2022 - 04/2006
6RNA (Ribonucleic Acid)IBA
01/2022 - 09/2004
6Biological ProductsIBA
01/2022 - 03/2009
6T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022 - 11/2018
6Small Interfering RNA (siRNA)IBA
01/2021 - 06/2008
6Vitamin EFDA LinkGeneric
11/2010 - 01/2008
5Transcription Factors (Transcription Factor)IBA
12/2022 - 01/2008
5AntioxidantsIBA
07/2022 - 06/2006
5Antineoplastic Agents (Antineoplastics)IBA
08/2021 - 06/2008
5CateninsIBA
01/2021 - 01/2015
5Hormones (Hormone)IBA
01/2018 - 04/2004
5FucosyltransferasesIBA
01/2017 - 09/2014
5Bortezomib (Velcade)FDA Link
12/2013 - 01/2007
4IronIBA
08/2021 - 05/2019
4LipidsIBA
08/2021 - 01/2018
4Interleukin-6 (Interleukin 6)IBA
01/2020 - 01/2016
4epigallocatechin gallate (epigallocatechin-3-gallate)IBA
01/2020 - 01/2016
4HMGB1 Protein (HMG1)IBA
08/2019 - 03/2014
4SialyltransferasesIBA
05/2019 - 02/2014
4DNA (Deoxyribonucleic Acid)IBA
04/2016 - 01/2008
4VitaminsIBA
12/2013 - 06/2007
4Acetic Acid (Vinegar)FDA LinkGeneric
11/2010 - 01/2008
4alpha-TocopherolFDA Link
10/2010 - 01/2008
4Caveolin 1IBA
03/2009 - 01/2006
3Circular RNAIBA
10/2022 - 01/2020
3PeriostinIBA
07/2022 - 06/2018
3Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 12/2017
3Liposomes (Liposome)IBA
08/2021 - 11/2007
3Glucose (Dextrose)FDA LinkGeneric
08/2021 - 05/2019
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2021 - 01/2007
3Competitive Endogenous RNAIBA
01/2020 - 01/2018
3Apoptosis Regulatory ProteinsIBA
01/2019 - 06/2008
3Ether (Diethyl Ether)IBA
11/2010 - 01/2008
3Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
08/2009 - 01/2007
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2008 - 05/2004
3Matrix Metalloproteinases (MMPs)IBA
01/2008 - 01/2006
3CurcuminIBA
01/2008 - 06/2006
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022 - 01/2019

Therapy/Procedure

38Therapeutics
06/2022 - 10/2008
13Drug Therapy (Chemotherapy)
08/2021 - 04/2013
12Castration
01/2019 - 05/2012
11Immunotherapy
03/2022 - 12/2016
8Radiotherapy
12/2019 - 08/2009
3Cell- and Tissue-Based Therapy (Cell Therapy)
11/2019 - 11/2018
3Catheter Ablation
01/2013 - 06/2011